NEW YORK – Vela Diagnostics said on Thursday it has received provisional authorization from Singapore's Health Sciences Authority for the firm's ViroKey SARS-CoV-2 RT-PCR Test.
As a result, Vela can offer the test to healthcare institutes, private hospitals, medical clinics, and clinical laboratories licensed in Singapore.